Sectors
Valeant Pharma investing in R&D; All eyes on Q4 results
Drug maker Valeant Pharmaceuticals International Inc is facing a variety of problems. Valeant has changed its aggressive investment strategy and turned keen on research and development. Valeant is also facing Federal investigation over its pricing strategies.
Japanese regional banks up lending on auto, holiday spending
Japan's regional banks are enhancing unsecured retail lending as it offers high profit margins. Loans on mortgage and small firm borrowing are declining. Japan banks are suffering from ultra-low interest rate regime to increase revenues.
US Presidential elections, China economy setting tone for markets
Global markets have been moving in tandem with state of Chinese economy and US Presidential elections these days. After rebounding in the previous month, the global markets are waiting for next level triggers from US elections and stimulus plans on China's economy.
Microsoft No Longer Accepts Bitcoin Payments
No more Bitcoin payments for Microsoft Windows 10 devices. Existing balance can still be used to purchase on Windows Store but cannot be refunded or added. Xbox users can still add Bitcoins to their accounts.